Myotis yumanensis (Yuma myotis): 139005903
Help
Entry
139005903 CDS
T10762
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
myum Myotis yumanensis (Yuma myotis)
Pathway
myum01524
Platinum drug resistance
myum04010
MAPK signaling pathway
myum04115
p53 signaling pathway
myum04148
Efferocytosis
myum04210
Apoptosis
myum04215
Apoptosis - multiple species
myum04623
Cytosolic DNA-sensing pathway
myum04650
Natural killer cell mediated cytotoxicity
myum04657
IL-17 signaling pathway
myum04668
TNF signaling pathway
myum04726
Serotonergic synapse
myum04932
Non-alcoholic fatty liver disease
myum04933
AGE-RAGE signaling pathway in diabetic complications
myum04936
Alcoholic liver disease
myum05010
Alzheimer disease
myum05012
Parkinson disease
myum05014
Amyotrophic lateral sclerosis
myum05016
Huntington disease
myum05020
Prion disease
myum05022
Pathways of neurodegeneration - multiple diseases
myum05132
Salmonella infection
myum05133
Pertussis
myum05134
Legionellosis
myum05145
Toxoplasmosis
myum05146
Amoebiasis
myum05152
Tuberculosis
myum05160
Hepatitis C
myum05161
Hepatitis B
myum05162
Measles
myum05163
Human cytomegalovirus infection
myum05164
Influenza A
myum05165
Human papillomavirus infection
myum05167
Kaposi sarcoma-associated herpesvirus infection
myum05168
Herpes simplex virus 1 infection
myum05169
Epstein-Barr virus infection
myum05170
Human immunodeficiency virus 1 infection
myum05200
Pathways in cancer
myum05203
Viral carcinogenesis
myum05205
Proteoglycans in cancer
myum05206
MicroRNAs in cancer
myum05210
Colorectal cancer
myum05222
Small cell lung cancer
myum05416
Viral myocarditis
myum05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
myum00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
139005903 (CASP3)
04668 TNF signaling pathway
139005903 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
139005903 (CASP3)
09143 Cell growth and death
04210 Apoptosis
139005903 (CASP3)
04215 Apoptosis - multiple species
139005903 (CASP3)
04115 p53 signaling pathway
139005903 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
139005903 (CASP3)
04650 Natural killer cell mediated cytotoxicity
139005903 (CASP3)
04657 IL-17 signaling pathway
139005903 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
139005903 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
139005903 (CASP3)
05206 MicroRNAs in cancer
139005903 (CASP3)
05205 Proteoglycans in cancer
139005903 (CASP3)
05203 Viral carcinogenesis
139005903 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
139005903 (CASP3)
05222 Small cell lung cancer
139005903 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
139005903 (CASP3)
05161 Hepatitis B
139005903 (CASP3)
05160 Hepatitis C
139005903 (CASP3)
05164 Influenza A
139005903 (CASP3)
05162 Measles
139005903 (CASP3)
05168 Herpes simplex virus 1 infection
139005903 (CASP3)
05163 Human cytomegalovirus infection
139005903 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
139005903 (CASP3)
05169 Epstein-Barr virus infection
139005903 (CASP3)
05165 Human papillomavirus infection
139005903 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
139005903 (CASP3)
05133 Pertussis
139005903 (CASP3)
05134 Legionellosis
139005903 (CASP3)
05152 Tuberculosis
139005903 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
139005903 (CASP3)
05145 Toxoplasmosis
139005903 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
139005903 (CASP3)
05012 Parkinson disease
139005903 (CASP3)
05014 Amyotrophic lateral sclerosis
139005903 (CASP3)
05016 Huntington disease
139005903 (CASP3)
05020 Prion disease
139005903 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
139005903 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
139005903 (CASP3)
05416 Viral myocarditis
139005903 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
139005903 (CASP3)
04932 Non-alcoholic fatty liver disease
139005903 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
139005903 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
139005903 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
myum01002
]
139005903 (CASP3)
Enzymes [BR:
myum01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
139005903 (CASP3)
Peptidases and inhibitors [BR:
myum01002
]
Cysteine peptidases
Family C14: caspase family
139005903 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
139005903
NCBI-ProteinID:
XP_070264271
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MDNTDNSVDSKSIKNSDIKPFHGSKSMDSGISLDDTYKMDYPEMGLCIIINNKNFDKSTG
MAPRSGTDVDAANLRETFTKLKYEVRNKNDLTREEIVELMCSVSKEDHSKRSSFVCVLLS
HGDEGIIFGTNGPVDLRKLTSFFRGDYCRSLAGKPKLFIIQACRGTELDCGIETDSNIDD
DMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKLYSHKLELMHILTRVN
RKVATEFESFSFDSTFHAKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggataacactgacaactcagtggattcaaagtccatcaagaattcggacataaagccc
ttccatggcagcaaatccatggactctgggatatccttggacgatacttacaagatggat
tatcctgaaatgggcttatgcatcataatcaataataagaactttgataaaagtactgga
atggcacctcggtcgggtacagatgttgatgcagcaaatctcagggaaacattcacaaaa
ttgaaatacgaagtcaggaacaaaaatgatcttacccgcgaggaaattgtggaactgatg
tgcagcgtttctaaagaagatcatagcaaaaggagcagttttgtttgcgtgcttctaagc
catggtgacgaaggaataatttttggaacaaatggacctgttgacttgagaaaattaaca
agttttttccgaggggattactgtagaagtctagctggaaagcccaaacttttcattatt
caggcctgccgaggaacagaactggactgcggtattgagactgacagcaatattgatgat
gacatggcatgtcagaaaataccagtggaggcagacttcttgtatgcgtattctacagca
cctggttactactcctggcgaaattcaaaggatggatcctggttcatccagtcgctttgt
gcgatgctgaagctgtactcgcacaagctggagctcatgcacatcctcactcgggttaac
cggaaggtagccacagaatttgagtccttctcctttgactctacttttcacgcaaagaaa
cagattccatgcattgtatctatgctcacaaaagaactgtatttttatcactaa
DBGET
integrated database retrieval system